What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Vikran Engineering (NSE: VIKRAN) Q3 FY26 results show solar-led order book surge as margins reset during execution ramp-up
Ducon Infratechnologies (NSE: DUCON) Q3 FY26 results signal margin pressure even as carbon capture and AI bets move closer to execution
Read More 5 minute read Pharma Industry News PharmaJet and Immuno Cure partner to launch needle-free HIV therapeutic DNA vaccine trial using Tropis intradermal device PharmaJet and Immuno Cure sign agreement to use the Tropis intradermal system in a needle-free human trial for a promising HIV DNA vaccine candidate. byPallavi MadhirajuJune 23, 2025